• Home
  • Contact
  • Phone: (267) 971-7725
  • Join our Facebook Group
  • Subscribe to our RSS Feed
  • Search Site

Bioquark

  • BackgroundMission & Strategy
  • The OpportunityThe Health Care Gap
  • Our ProgramsBioquantines
    • BQ-A
    • BQ-A In-Vivo Studies
    • BQ-A Clinical Plans
    • Health, Wellness and Beauty Care
    • Articles / Shows / Press Releases / Publications
    • Future Bioquantine Programs
  • About UsOur History
    • Our Team
  • Contact UsGet in Touch

You are here: Bioquark / Bioquantine Programs / BQ-A In-Vivo Studies

BQ-A In-Vivo Studies

BQ-A has been tested in the animal models listed below and has been administered by several methods including subcutaneously, intraperitoneally, intratumorally, and topically. These studies have served to highlight broad potential across a range of tissues and administration methods, as well as to validate the universal nature of its tissue remodeling concept.

Traumatic Brain Injury (TBI) – standard weight drop model of mouse TBI – BQ-A demonstrated improvement in gross anatomical changes, reductions in B-amyloid protein expression, and improvements in hippocampus impaired spatial learning and memory during Morris water navigation task

Melanoma – BL6 melanoma mouse xenografts – BQ-A demonstrated shrinkage of tumor size, prevention of new tumor formation, and reduction in tumor invasiveness biomarkers

Skin Wrinkling – squalene monohydroperoxide induced wrinkling model in hairless mouse – BQ-A demonstrated enhanced reversal of skin wrinkling

Hair Loss (Alopecia) – induced alopecia – BQ-A demonstrated re-growth of hair

Gerontological (Aging) – conducted chronic administration in both mice and fruit flies (Drosophila melanogaster) – Experimental mice lived 1.7 times longer than animals in control group and experimental Drosophila melanogaster flies lived 2.2 times longer than control group.

The longest administration of BQ-A in a disease model has been 45 days. The longest administration in a healthy animal has been for over one year. While not a formal safety study, from an observational perspective no growths, abscesses, infections, immune reactions, or behavioral changes have been seen in these animals, highlighting an intriguing and promising safety profile.

  • BQ-A
  • BQ-A In-Vivo Studies
  • BQ-A Clinical Plans
  • Health, Wellness and Beauty Care
  • Articles / Shows / Press Releases / Publications
  • Future Bioquantine Programs
Bioquark Inc. is a life sciences company, developing proprietary combinatorial biologics for the regeneration and repair of human organs and tissues.

BQ-A

BQ-A represents the first in a class of tissue regulatory state modifiers, which interact with the control apparatus of the genome to affect disease cure. (read more)

BQ-A In-Vivo Studies

BQ-A has been administered by several methods including subcutaneously, intraperitoneally, intratumorally, and topically. (read more)

BQ-A Clinical Plans

Bioquark is focusing on generating human clinical data in multiple therapeutic indications of unmet medical need. (read more)
© Copyright - Bioquark
  • scroll to top
  • Join our Facebook Group
  • Subscribe to our RSS Feed